Vaccination Coverage for Medically Indicated Vaccines in a Convenience Sample of Severely Immunocompromised Patients with COVID-19: An Observational Cohort Study
Elsemieke te Linde, Marjolein P M Hensgens, Albert M Vollaard, Annelies Verbon, Anke H W Bruns, Victor Adekanmbi · 2024
Read Vaccination Coverage for Medically Indicated Vaccines in a Convenience Sample of Severely Immunocompromised Patients with COVID-19: An Observational Cohort Study by Elsemieke te Linde, Marjolein P M Hensgens, Albert M Vollaard, Annelies Verbon, Anke H W Bruns, Victor Adekanmbi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11680350.txt.
Description
Elsemieke te Linde and co-authors (2024) measure how many severely immunocompromised patients actually receive the extra vaccines their condition calls for. People with weakened immune systems face dangerous infections, so guidelines offer them added shots: pneumococcal, shingles, HPV, flu, and COVID vaccines among them. Uptake, though, is rarely audited. The team studied adults admitted with COVID-19 to a Dutch university hospital between September 2021 and April 2022.
Each patient answered a questionnaire about their vaccination history and past vaccine-preventable infections. The team then checked those reports against the patients' medical records, a cross-check that exposes both missed shots and faulty memory. The coverage figures show where protection falls short in exactly the group with most to lose. The authors intend the audit as a baseline for closing the gaps, since a recommended vaccine only helps if it is given.
Catalog record
| CREATOR | Elsemieke te Linde, Marjolein P M Hensgens, Albert M Vollaard, Annelies Verbon, Anke H W Bruns, Victor Adekanmbi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |